Published • loading... • Updated
Semaglutide Shifts Inflammation Blood Markers in Diabetes, With a Twist for
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Semaglutide Shifts Inflammation Blood Markers in Diabetes, With a Twist for
A retrospective study of 99 patients in Saudi Arabia found that semaglutide significantly altered systemic inflammation index ratios in type 2 diabetes, with the correlation between C-reactive protein and a composite neutrophil-lymphocyte-platelet ratio flipping direction depending on whether patients had diabetic retinopathy.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
